Latest call day: 2026-10-23 · full consensus board · graded history
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Today's calls AI
| Biotech · Momentum Acceleration | UP 86% | Momentum Acceleration — trend speeding up. REGN ranks #2 of 8 in Biotech (86% bullish percentile, signal +17.8%), so the agent calls it UP for the next session. |
| Biotech · SOTA Ensemble | UP 86% | SOTA Ensemble — a purged-CV rank ensemble (gradient-boosting + ridge + momentum). REGN ranks #2 of 8 in Biotech (86% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Donchian | UP 57% | Donchian — position within the Donchian channel. REGN ranks #4 of 8 in Biotech (57% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · MACD | UP 57% | MACD — MACD histogram momentum crossover. REGN ranks #4 of 8 in Biotech (57% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Momentum | UP 43% | Momentum — trailing return (trend-following). REGN ranks #5 of 8 in Biotech (43% bullish percentile, signal +2.9%), so the agent calls it UP for the next session. |
| Biotech · Volume Thrust | UP 14% | Volume Thrust — volume-confirmed accumulation. REGN ranks #7 of 8 in Biotech (14% bullish percentile), so the agent calls it UP for the next session. |
Best agents on REGN (graded record)
| Mean-Reversion Agent | 100% | 1/1 correct | DOWN |
| Biotech · 52-Week-High | 62% | 8/13 correct | UP |
| Biotech · Breakout | 61% | 19/31 correct | DOWN |
| Biotech · LightGBM | 54% | 26/48 correct | DOWN |
| Biotech · Long-Term Reversal | 54% | 13/24 correct | UP |
| Biotech · Relative Strength | 53% | 8/15 correct | UP |
| Biotech · Low Volatility | 53% | 10/19 correct | UP |
| Biotech · Momentum | 52% | 41/79 correct | UP |
| Biotech · Bollinger Reversion | 51% | 19/37 correct | UP |
| Biotech · Donchian | 51% | 39/76 correct | UP |
Recent news
| 2026-10-23 | 1 safe-and-steady stock with exciting potential and 2 facing headwinds · yf_tkr_REGN |
| 2026-10-23 | Regeneron (REGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release · yf_tkr_REGN |
| 2026-10-21 | Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Gets Price Target Bump from TD Cowen · MarketBeat |
| 2026-10-21 | TD Cowen maintains Buy rating on Regeneron Pharmaceuticals, $980 price target · TradingView |
| 2026-10-19 | Strong Dupixent Trajectory Anchors Regeneron Pharmaceuticals’ (REGN) Solid Financial Results · Yahoo Finance |
| 2026-10-19 | Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $865.00 Price Target at Piper Sandler · MarketBeat |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。